ICG pharmaceutical diagnostic, known in a number of territories as VERDYE™, is well known and accepted by surgeons worldwide (over 11,000 published articles on use and applications)*
*Pubmed
** https://radiologykey.com/clinical-applications-of-diagnostic-indocyanine-green-angiography/
***https://www.ncbi.nlm.nih.gov/pubmed/635011
Active Substance: Indocyanine Green.
Warnings and Precautions
Do not use ICG Product if:
Take special care with ICG Pharmaceutical Product if:
you suffer from kidney failure. Consult your doctor to see whether this medicine is suitable for you.
you need to have a test called “radio-active iodine uptake”, a test which assesses how well your thyroid gland functions. This test should be delayed for at least a week after you have received the ICG Pharmaceutical Product, because the injection could affect the outcome of the thyroid test.
you are taking any drugs, refer to the Product Information Leaflet for a list of drugs affected by ICG Pharmaceutical Product.
To report SUSPECTED ADVERSE REACTIONS
All suspected drug reactions and product compliance associated with our ICG Pharmaceutical Product should be reported to:
Email: ICG@drugsafety.de; Phone: +49 171 3860445; Email info@diagnosticgreen.com
VERDYE™ 25 mg/50 mg. Active substance: indocyanine green, monosodium salt. Composition: 25 mg /50 mg powder for producing an injectable solution; 1 ml of the injectable solution contains 5 mg of the active substance. Other ingredients: none. Indications: diagnostic drug which is used to determine the effectiveness of the blood supply to the heart, brain and other organs and to one of the inner layers of the eye (choroid), as well as for monitoring the circulation of blood and determining liver function. Contraindications: hypersensitivity (allergy) to indocyanine green, sodium iodide or iodine; overactive thyroid or discrete benign thyroid tumours or if parts of your thyroid are no longer under hormonal influence. Do not use if you have ever had any side effects after receiving an ICG injection (risk of anaphylactic reaction). No use in premature babies and new-borns suffering from hyperbilirubinaemia. Side-effects: very rare (<1 in 10,000): nausea and hypersensitivity reactions (allergies); the possibility of an allergic reaction is greater in patients with extremely serious kidney failure. Possible symptoms: restlessness, hot flushes, nausea, itching, hives (skin rash), faster heartbeat, facial redness, swelling of the face (facial oedema), drop in blood pressure, shortness of breath, spasms of the bronchia and larynx, cardiac/circulatory arrest, death. Associated with the allergic reaction an increase of special white blood cells can occur. Prescription only. Diagnostic Green GmbH, Aschheim-Dornach, Germany, April, 2019.
